A positive association was found between GRK6 and Ki-67 expression, pathological disease stage, metastasis, and survival rate in the patients with hepatocellular carcinoma, and GRK6 was hypothesized as a biomarker for the early diagnosis of hepatocellular carcinoma [148]. This evidence concerns the gene MKI67 and hepatocellular carcinoma.